As of 2025-07-13, the EV/EBITDA ratio of AVITA Medical Inc (RCEL) is -3.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVITA's latest enterprise value is 177.25 mil USD. AVITA's TTM EBITDA according to its financial statements is -49.70 mil USD. Dividing these 2 quantities gives us the above AVITA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 13.3x | 12.4x |
| Forward P/E multiples | 20.5x - 41.3x | 30.9x |
| Fair Price | (39.55) - (26.02) | (41.72) |
| Upside | -793.9% - -556.4% | -831.9% |
| Date | EV/EBITDA |
| 2025-07-11 | -3.57 |
| 2025-07-10 | -3.69 |
| 2025-07-09 | -3.53 |
| 2025-07-08 | -3.52 |
| 2025-07-07 | -3.28 |
| 2025-07-03 | -3.42 |
| 2025-07-02 | -3.28 |
| 2025-07-01 | -3.34 |
| 2025-06-30 | -3.35 |
| 2025-06-27 | -3.43 |
| 2025-06-26 | -3.26 |
| 2025-06-25 | -3.07 |
| 2025-06-24 | -3.16 |
| 2025-06-23 | -3.27 |
| 2025-06-20 | -3.28 |
| 2025-06-18 | -3.33 |
| 2025-06-17 | -3.31 |
| 2025-06-16 | -3.44 |
| 2025-06-13 | -3.48 |
| 2025-06-12 | -3.62 |
| 2025-06-11 | -3.76 |
| 2025-06-10 | -3.72 |
| 2025-06-09 | -3.78 |
| 2025-06-06 | -3.78 |
| 2025-06-05 | -3.59 |
| 2025-06-04 | -3.69 |
| 2025-06-03 | -3.65 |
| 2025-06-02 | -3.75 |
| 2025-05-30 | -3.52 |
| 2025-05-29 | -3.60 |
| 2025-05-28 | -3.84 |
| 2025-05-27 | -3.76 |
| 2025-05-23 | -3.87 |
| 2025-05-22 | -3.94 |
| 2025-05-21 | -4.00 |
| 2025-05-20 | -4.10 |
| 2025-05-19 | -4.12 |
| 2025-05-16 | -3.97 |
| 2025-05-15 | -3.92 |
| 2025-05-14 | -4.09 |
| 2025-05-13 | -4.26 |
| 2025-05-12 | -4.39 |
| 2025-05-09 | -4.24 |
| 2025-05-08 | -5.50 |
| 2025-05-07 | -5.57 |
| 2025-05-06 | -5.43 |
| 2025-05-05 | -5.43 |
| 2025-05-02 | -5.45 |
| 2025-05-01 | -5.50 |
| 2025-04-30 | -5.69 |